Summary
Normal human mammary epithelial cells (HMEC) from different individual reduction mammoplasty specimens were all growth inhibited, and showed a flattened, elongated morphology in response to human recombinant transforming growth factor β1 (TGFβ). The degree of growth inhibition varied among specimens, but none of the normal HMEC maintained growth in the continued presence of TGFβ. The degree of growth inhibition also varied with cell age in vitro, cells closer to senescence being more sensitive. TGFβ sensitivity was additionally assayed in two established cell lines derived from one of the reduction mammoplasty specimens after exposure to benzo(a)pyrene. Although varying degrees of growth inhibition and morphologic changes were observed in the cell lines, both lines contained populations that maintained active growth in the presence of TGFβ. Subclones of these lines demonstrated a great plasticity in their growth response to TGFβ, with individual clones ranging from strongly growth inhibited to nearly unaffected. These results suggest that multiple factors influence the extent of TGFβ-induced growth effects on both normal and transformed mammary epithelial cells, and that some of these factors may act through epigenetic mechanisms.
Similar content being viewed by others
References
Cheifetz, S.; Weatherbee, J. A.; Tsang-S, M. L. The transforming growth factor-β system, a complex pattern of cross-reactive ligands and receptors. Cell. 48:409–415; 1987.
Clark, R.; Stampfer, M.; Milley, B., et al. Transformation of human mammary epithelial cells by oncogenic retroviruses. Cancer Res. 48:4689–4694; 1988.
Coffey, R. J.; Bascom, C. C.; Sipes, N. J., et al. Growth modulation of mouse keratinocytes by transforming growth factors. Cancer Res. 48:1596–1602; 1988.
Fernandez-Pol, J. A.; Klos, D. J.; Hamilton, P. D., et al. Modulation of epidermal growth factor receptor gene expression by transforming growth factor-β in a human breast carcinoma cell line. Cancer Res. 47:4260–4265; 1987.
Hammond, S. L.; Ham, R. G.; Stampfer, M. R. Serum-free growth of human mammary epithelial cells: rapid clonal growth in defined medium and extended serial passage with pituitary extract. Proc. Natl. Acad. Sci. USA 81:5435–5439; 1984.
Holley, R. W.; Armour, R.; Baldwin, H. J., et al. Activity of a kidney epithelial cell growth inhibitor on lung and mammary cells. Cell Biol. Int. Rep. 7:141–147; 1983.
Holley, R. W.; Bohlen, P.; Fava, R., et al. Purification of kidney epithelial cell growth inhibitors. Proc. Natl. Acad. Sci. USA 77:5989–5992; 1980.
Ignotz, R. A.; Endo, T.; Massague, J. Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-β. J. Biol. Chem. 262:6443–6446; 1987.
Jetten, A. M.; Shirley, J. E.; Stoner, G. Regulation of proliferation and differentiation of respiratory tract epithelial cells by TGFβ. Exp. Cell Res. 167:539–549; 1986.
Lund, L. R.; Riccio, A.; Andreasen, P. A., et al. Transforming growth factor-β is a strong and fast positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts. EMBO J. 6:1281–1286; 1987.
Massague, J. The TGF-β family of growth and differentiation factors. Cell. 49:437–438; 1987.
Masui, T.; Wakefield, L. M.; Lechner, J. F., et al. Type β transforming factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial. Proc. Natl. Acad. Sci. USA 83:2438–2442; 1986.
McMahon, J. B.; Richard, W. L.; del Campo, A. A., et al. Differential effects of transforming growth factor-β on proliferation of normal and malignant rat liver epithelial cells. Cancer Res. 46:4665–4671; 1986.
Roberts, A. B.; Anzano, M. A.; Lamb, L. C., et al. New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues. Proc. Natl. Acad. Sci. USA 78:5339–5343; 1981.
Roberts, A. B.; Anzano, M. A.; Wakefield, L. M., et al. Type β transforming growth factor: a bifunctional regulator of cellular growth. Proc. Natl. Acad. Sci. USA 82:119–123; 1985.
Roberts, A. B.; Sporn, M. B.; Assoian, R. K., et al. Transforming growth factor type-beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. USA 83:4167–4171; 1986.
Shipley, G. D.; Pittelkow, M. R.; Wille, J. J., et al. Reversible inhibition of normal human prokeratinocyte proliferation by type β transforming growth factor-growth inhibitor in serum-free medium. Cancer Res. 46:2608–2071; 1986.
Silberstein, G. B.; Daniel, C. W. Reversible inhibition of mammary gland growth by transforming growth factor-β. Science. 237:291–293; 1987.
Sporn, M. B.; Roberts, A. B.; Wakefield, L. M., et al. Some recent advances in the chemistry and biology of transforming growth factor-beta. J. Cell. Biol. 105:1039–1045; 1987.
Stampfer, M. R. Cholera toxin stimulation of human mammary epithelial cells in culture. In Vitro 18:531–537; 1982.
Stampfer, M. R. Isolation and growth of human mammary epithelial cells. J. Tissue Cult. Methods 9:107–116; 1985.
Stampfer, M.; Alhadeff, M.; Prosen, D., et al. Effects of transforming growth factor β on human mammary epithelial cells in culture. J. Cell Biochem. 13B(Suppl):97; 1989.
Stampfer, M. R.; Bartley, J. C. Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo(a)pyrene. Proc. Natl. Acad. Sci. USA 82:2394–2398; 1985.
Stampfer, M. R.; Bartley, J. C. Human mammary epithelial cells in culture: differentiation and transformation. In: Dickson, R. B.; Lippman, M. E.; Norwall, M. A. eds Breast cancer: cellular and molecular biology, Norwall: Kluwer Academic Publishers; 1988:1–24.
Takehara, K.; LeRoy, C.; Grotendorst, G. R. TGF-β inhibition of endothelial cell proliferation: alteration of EGF binding and EGF-induced growth-regulatory (competence) gene expression. Cell 49:415–422; 1987.
Tucker, R. F.; Shipley, G. D.; Moses, H. L., et al. Growth inhibitor from BSC-1 cells closely related to the platelet type beta transforming growth factor. Science 226:705–707; 1984.
Valverius, E.; Bates, S. E.; Stampfer, M. R., et al. Transforming growth factor alpha production and EGF receptor expression in normal and oncogene transformed human mammary epithelial cells. Mol. Endocrinol. 3:203–214; 1989.
Valverius, E.; Walker-Jones, E.; Bates, S. E., et al. Inhibition of human breast epithelial cells with transforming growth factor β and desensitization by oncogene mediated transformation. Proc. Am. Assoc. Cancer Res. 29:249; 1988.
Wakefield, L. M.; Smith, D. M.; Masui, T., et al. Distribution and modulation of the cellular receptor for transforming growth factor-beta. J. Cell Biol. 105:965–975; 1987.
Wallen, K.; Stampfer, M. R. Chromosome analyses of human mammary epithelial cells at stages of chemically-induced transformation progression to immortality. Cancer Gen. Cyto. 37:249–261; 1989.
Wilkner, N. E.; Persichitte, K. A.; Baskin, J. B., et al. Transforming growth factor-β stimulates the expression of fibronectin by human keratinocytes. J. Invest. Dermatol. 91:207–212; 1988.
Wollenberg, G. K.; Semple, E.; Quinn, B. A., et al. Inhibition of proliferation of normal preneoplastic, and neoplastic rat hepatocytes by transforming growth factor-β. Cancer Res. 47:6595–6599; 1987.
Author information
Authors and Affiliations
Additional information
This work was supported by CA24844 from the National Institutes of Health, Bethesda, MD, and the Office of Energy Research, Office of Health and Environmental Research of the U.S. Department of Energy under contract DE-AC03-76SF00098.
Rights and permissions
About this article
Cite this article
Hosobuchi, M., Stampfer, M.R. Effects of transforming growth factor β on growth of human mammary epithelial cells in culture. In Vitro Cell Dev Biol 25, 705–713 (1989). https://doi.org/10.1007/BF02623723
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02623723